Post-Surgical Biomarkers for Predicting Cancer Recurrence
Maja Lindholm*
Received Date: Nov 02, 2024 / Published Date: Nov 30, 2024
Abstract
The ability to predict cancer recurrence after surgery is a critical aspect of cancer care, influencing decisions regarding post-operative surveillance and adjuvant therapies. Post-surgical biomarkers, which include genetic, proteomic, and epigenetic markers, provide important insights into the likelihood of recurrence in patients with various types of cancer. These biomarkers can help clinicians identify high-risk patients who may benefit from closer monitoring or additional treatments, ultimately improving patient outcomes. This article discusses the current landscape of post- surgical biomarkers, their predictive capabilities, and the potential for integrating these markers into routine clinical practice for cancer management.
Citation: Maja L (2024) Post-Surgical Biomarkers for Predicting Cancer Recurrence. Cancer Surg, 9: 142. Doi: 10.4172/2573-542X.1000142
Copyright: © 2024 Maja L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Share This Article
Recommended Journals
51ºÚÁϳԹÏÍø Journals
Article Tools
Article Usage
- Total views: 313
- [From(publication date): 0-0 - Apr 30, 2025]
- Breakdown by view type
- HTML page views: 139
- PDF downloads: 174
